Biology of Transforming Growth Factor-β Signaling

被引:48
作者
Ikushima, Hiroaki [1 ]
Miyazono, Kohei [1 ]
机构
[1] Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Tokyo 1130033, Japan
关键词
TGF-beta; Smad; non-Smad; cell proliferation; fibrosis; EMT; EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; TGF-BETA; CRYSTAL-STRUCTURE; C-MYC; MEDIATED DEGRADATION; NEGATIVE REGULATORS; CELLULAR-RESPONSES; TUMOR-SUPPRESSOR; SMAD PROTEINS;
D O I
10.2174/138920111798808419
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transforming growth factor (TGF)-beta signaling has been implicated as an important regulator of almost all major cell behaviors, including proliferation, differentiation, cell death, and motility. Which cell responses are induced or suppressed in response to TGF-beta depends on the cell type and the context in which TGF-beta signaling is received. TGF-beta ligands, their receptors, and intracellular Smad effectors lie in the center of TGF-beta signaling. TGF-beta ligands signal via receptor serine/threonine kinases that phosphorylate and activate Smad proteins as well as other signaling molecules. Smad complexes associate with chromatin and regulate transcription, defining the biological response of a cell to TGF-beta stimulation. In addition, numerous factors constitute complex networks to regulate TGF-beta signaling and to provide this cytokine with the ability to induce cellular context-specific cell responses. Perturbation of the network is strongly involved in various pathological situations, including cancer and fibrosis. In this review, we consider the basic machinery of TGF-beta signaling and describe several factors which make up TGF-beta signaling networks. We also address major TGF-beta-induced cell responses involved in several physiological and pathological conditions, including cell proliferation, fibrosis, and epithelial-mesenchymal transition.
引用
收藏
页码:2099 / 2107
页数:9
相关论文
共 50 条
  • [21] TRANSFORMING GROWTH FACTOR-β SIGNALING IS UPREGULATED IN SPORADIC INCLUSION BODY MYOSITIS
    Noda, Seiya
    Koike, Haruki
    Maeshima, Shinya
    Nakanishi, Hirotaka
    Iijima, Masahiro
    Matsuo, Koji
    Kimura, Seigo
    Katsuno, Masahisa
    Sobue, Gen
    MUSCLE & NERVE, 2017, 55 (05) : 741 - 747
  • [22] Distinct roles of transforming growth factor-β signaling and transforming growth factor-β receptor inhibitor SB431542 in the regulation of p21 expression
    Koo, Bon-Hun
    Kim, Yeaji
    Cho, Yang Je
    Kim, Doo-Sik
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 764 : 413 - 423
  • [23] Transforming growth factor-β signalling pathway in tendon healing
    Li, Yujie
    Liu, Xinyue
    Liu, Xueli
    Peng, Yuanqiu
    Zhu, Bin
    Guo, Sheng
    Wang, Chenglong
    Wang, Dingxuan
    Li, Sen
    GROWTH FACTORS, 2022, 40 (3-4) : 98 - 107
  • [24] Transforming growth factor-β in cancer and metastasis
    Jakowlew, Sonia B.
    CANCER AND METASTASIS REVIEWS, 2006, 25 (03) : 435 - 457
  • [25] Transforming growth factor-β in cutaneous melanoma
    Javelaud, Delphine
    Alexaki, Vasileia-Ismini
    Mauviel, Alain
    PIGMENT CELL & MELANOMA RESEARCH, 2008, 21 (02) : 123 - 132
  • [26] The Smad pathway in transforming growth factor-β signaling
    Haiyan Lin
    Hongmei Wang
    Cheng Zhu
    Science in China Series C: Life Sciences, 2003, 46 : 449 - 463
  • [27] The Smad pathway in transforming growth factor-β signaling
    林海燕
    王红梅
    祝诚
    Science in China(Series C:Life Sciences), 2003, (05) : 449 - 463
  • [28] Smad proteins and transforming growth factor-β signaling
    Schiffer, M
    Von Gersdorff, G
    Bitzer, M
    Susztak, K
    Böttinger, EP
    KIDNEY INTERNATIONAL, 2000, 58 : S45 - S52
  • [29] The Smad pathway in transforming growth factor-β signaling
    Lin, HY
    Wang, HM
    Zhu, C
    SCIENCE IN CHINA SERIES C-LIFE SCIENCES, 2003, 46 (05): : 449 - 463
  • [30] Insights into the Transforming Growth Factor-β Signaling Pathway in Cutaneous Melanoma
    Perrot, Carole Yolande
    Javelaud, Delphine
    Mauviel, Alain
    ANNALS OF DERMATOLOGY, 2013, 25 (02) : 135 - 144